Document Detail


Hemodynamic, Hormonal and Renal Effects of (Pro)Renin Receptor Blockade in Experimental Heart Failure.
MedLine Citation:
PMID:  22798523     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: -The (pro)renin receptor (P)RR is implicated in blood pressure regulation and the pathophysiology of heart failure. The effects of (P)RR blockade in heart failure have not previously been investigated. METHODS AND RESULTS: -Eight sheep received on two separate days a vehicle control and incremental intravenous boluses of a (P)RR antagonist, ovine handle region peptide (HRP)(1, 5 and 25mg at 90min intervals), both before (Normal) and after induction of heart failure by rapid left ventricular pacing. In Normal sheep, HRP reduced heart rate (p<0.001) and hematocrit (p=0.019) compared to time-matched control data, without significantly affecting any other hemodynamic, hormonal or renal variables. In sheep with heart failure, HRP treatment induced progressive falls in mean arterial pressure (p<0.001) in association with decreases in left atrial pressure (p<0.001), peripheral resistance (p=0.014) and hematocrit (p<0.001). Cardiac contractility tended to decline (p=0.096), whereas cardiac output was unaltered. HRP administration produced a dose-dependent decrease in plasma renin activity (p=0.004), with similar trends observed for plasma angiotensin II and aldosterone (p=0.093 and p=0.088, respectively). Circulating natriuretic peptides, endothelin-1 and catecholamine levels were unchanged. HRP also induced a reduction in plasma sodium concentrations relative to control (p=0.024), a natriuresis (p=0.046) and a tendency for creatinine excretion and clearance to improve. CONCLUSIONS: -(P)RR antagonism in experimental heart failure resulted in cardiovascular and renal benefits in association with inhibition of the renin-angiotensin-aldosterone system. These findings suggest that (P)RR contributes to pressure/volume regulation in heart failure, and identifies the receptor as a potential therapeutic target in this disease.
Authors:
Miriam T Rademaker; Tim G Yandle; Leigh J Ellmers; Christopher J Charles; M Gary Nicholls; A Mark Richards
Related Documents :
12367823 - Programmed hypertension: kidney, brain or both?
10227413 - Selecting screening criteria for clinical trials: an example from the systolic hyperten...
12367823 - Programmed hypertension: kidney, brain or both?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-12
Journal Detail:
Title:  Circulation. Heart failure     Volume:  -     ISSN:  1941-3297     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101479941     Medline TA:  Circ Heart Fail     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Christchurch Cardioendocrine Research Group, University of Otago, Christchurch, New Zealand.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mineralocorticoid Receptor Antagonists and Cardiovascular Mortality in Patients with Atrial Fibrilla...
Next Document:  Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myo...